These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 12356774)

  • 1. A single amino acid difference between human and monkey interleukin (IL)-1beta dictates effective binding to soluble type II IL-1 receptor.
    Smith DE; Ketchem RR; Moore H; Anderson Z; Renshaw BR; Friend DJ; Sims JE
    J Biol Chem; 2002 Dec; 277(49):47619-25. PubMed ID: 12356774
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Crystal structure of the type-I interleukin-1 receptor complexed with interleukin-1beta.
    Vigers GP; Anderson LJ; Caffes P; Brandhuber BJ
    Nature; 1997 Mar; 386(6621):190-4. PubMed ID: 9062193
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mapping receptor binding sites in interleukin (IL)-1 receptor antagonist and IL-1 beta by site-directed mutagenesis. Identification of a single site in IL-1ra and two sites in IL-1 beta.
    Evans RJ; Bray J; Childs JD; Vigers GP; Brandhuber BJ; Skalicky JJ; Thompson RC; Eisenberg SP
    J Biol Chem; 1995 May; 270(19):11477-83. PubMed ID: 7744786
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cloning and characterization of an alternatively processed human type II interleukin-1 receptor mRNA.
    Liu C; Hart RP; Liu XJ; Clevenger W; Maki RA; De Souza EB
    J Biol Chem; 1996 Aug; 271(34):20965-72. PubMed ID: 8702856
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular cloning and expression of cynomolgus monkey interleukin-1beta cDNA.
    Totsuka K; Takakura H; Hashimoto O; Tatsumi M
    Int Arch Allergy Immunol; 1998 May; 116(1):40-8. PubMed ID: 9623508
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Deletion mutants of human interleukin 1 beta with significantly reduced agonist properties: search for the agonist/antagonist switch in ligands to the interleukin 1 receptors.
    Simoncsits A; Bristulf J; Tjörnhammar ML; Cserzö M; Pongor S; Rybakina E; Gatti S; Bartfai T
    Cytokine; 1994 Mar; 6(2):206-14. PubMed ID: 8032002
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The soluble form of IL-1 receptor accessory protein enhances the ability of soluble type II IL-1 receptor to inhibit IL-1 action.
    Smith DE; Hanna R; Della Friend ; Moore H; Chen H; Farese AM; MacVittie TJ; Virca GD; Sims JE
    Immunity; 2003 Jan; 18(1):87-96. PubMed ID: 12530978
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A mutational analysis of receptor binding sites of interleukin-1 beta: differences in binding of human interleukin-1 beta muteins to human and mouse receptors.
    Grütter MG; van Oostrum J; Priestle JP; Edelmann E; Joss U; Feige U; Vosbeck K; Schmitz A
    Protein Eng; 1994 May; 7(5):663-71. PubMed ID: 8073036
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IL-1beta epitope mapping using site-directed mutagenesis and hydrogen-deuterium exchange mass spectrometry analysis.
    Lu J; Witcher DR; White MA; Wang X; Huang L; Rathnachalam R; Beals JM; Kuhstoss S
    Biochemistry; 2005 Aug; 44(33):11106-14. PubMed ID: 16101294
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of the discontinuous binding site in human interleukin 1 beta for the type I interleukin 1 receptor.
    Labriola-Tompkins E; Chandran C; Kaffka KL; Biondi D; Graves BJ; Hatada M; Madison VS; Karas J; Kilian PL; Ju G
    Proc Natl Acad Sci U S A; 1991 Dec; 88(24):11182-6. PubMed ID: 1837145
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Site-directed mutagenesis--molecular biology and rational drug design.
    Ju G; Labriola-Tompkins E; Varnell T; Madison V; Graves B
    Agents Actions Suppl; 1995; 47():155-9. PubMed ID: 7785490
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The first two N-terminal immunoglobulin-like domains of soluble human IL-1 receptor type II are sufficient to bind and neutralize IL-1beta.
    Kollewe C; Neumann D; Martin MU
    FEBS Lett; 2000 Dec; 487(2):189-93. PubMed ID: 11150507
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cloning of a novel receptor subunit, AcPL, required for interleukin-18 signaling.
    Born TL; Thomassen E; Bird TA; Sims JE
    J Biol Chem; 1998 Nov; 273(45):29445-50. PubMed ID: 9792649
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of regions in interleukin-1 alpha important for activity.
    Gayle RB; Poindexter K; Cosman D; Dower SK; Gillis S; Hopp T; Jerzy R; Kronheim S; Lum V; Lewis A
    J Biol Chem; 1993 Oct; 268(29):22105-11. PubMed ID: 8408069
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mapping of neutralizing epitopes and the receptor binding site of human interleukin 1 beta.
    Simon PL; Kumar V; Lillquist JS; Bhatnagar P; Einstein R; Lee J; Porter T; Green D; Sathe G; Young PR
    J Biol Chem; 1993 May; 268(13):9771-9. PubMed ID: 7683661
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A search within the IL-1 type I receptor reveals a peptide with hydropathic complementarity to the IL-1beta trigger loop which binds to IL-1 and inhibits in vitro responses.
    Heal JR; Bino S; Ray KP; Christie G; Miller AD; Raynes JG
    Mol Immunol; 1999 Dec; 36(17):1141-8. PubMed ID: 10698316
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IL-1 Family Cytokines Use Distinct Molecular Mechanisms to Signal through Their Shared Co-receptor.
    Günther S; Deredge D; Bowers AL; Luchini A; Bonsor DA; Beadenkopf R; Liotta L; Wintrode PL; Sundberg EJ
    Immunity; 2017 Sep; 47(3):510-523.e4. PubMed ID: 28930661
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cloning of a cDNA encoding a novel interleukin-1 receptor related protein (IL 1R-rp2).
    Lovenberg TW; Crowe PD; Liu C; Chalmers DT; Liu XJ; Liaw C; Clevenger W; Oltersdorf T; De Souza EB; Maki RA
    J Neuroimmunol; 1996 Nov; 70(2):113-22. PubMed ID: 8898719
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structure-function analysis of human IL-1 alpha: identification of residues required for binding to the human type I IL-1 receptor.
    Labriola-Tompkins E; Chandran C; Varnell TA; Madison VS; Ju G
    Protein Eng; 1993 Jul; 6(5):535-9. PubMed ID: 7692435
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Loop substitution as a tool to identify active sites of interleukin-1 beta.
    Palla E; Bensi G; Solito E; Buonamassa DT; Fassina G; Raugei G; Spano F; Galeotti C; Mora M; Domenighini M
    J Biol Chem; 1993 Jun; 268(18):13486-92. PubMed ID: 7685764
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.